SCHEMBL4070308

SCHEMBL4070308

O=S1(=O)CS(=O)(=O)OCOCOCO1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576116 0.83
SCHEMBL14133784 0.71
SCHEMBL19494794 0.70
Dimethyl Sulfoxide SCHEMBL28414639 0.69
SCHEMBL706795 0.67
SCHEMBL13035882 0.67
SCHEMBL575916 0.65
SCHEMBL17973357 0.63 TSHR (0.32) TSHR
SCHEMBL6015190 0.61 TSHR (1.00) TSHR
SCHEMBL22490 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230344002-A1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2023-10-26 US disclosed
US-20230327200-A1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2023-10-12 US disclosed
US-20230062771-A1 LITHIUM ION SECONDARY BATTERY Envision Aesc Energy Devices Ltd. (JP) 2023-03-02 US disclosed
US-10777817-B2 Lithium ion secondary battery NEC CORPORATION (JP) 2020-09-15 US disclosed
US-20200144668-A1 LITHIUM ION SECONDARY BATTERY, MANUFACTURING METHOD OF LITHIUM ION SECONDARY BATTERY, AND ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY Envision Aesc Energy Devices Ltd. (JP) 2020-05-07 US disclosed
US-20200028212-A1 LITHIUM ION SECONDARY BATTERY Envision Aesc Energy Devices Ltd. (JP) 2020-01-23 US disclosed
EP-2827433-B1 SECONDARY BATTERY ELECTROLYTE AND SECONDARY BATTERY USING SAME ENVISION AESC ENERGY DEVICES LTD (JP) 2019-09-25 EP disclosed
US-10224568-B2 Electrolytic solution and secondary battery NEC CORPORATION (JP) 2019-03-05 US disclosed
US-10211451-B2 Negative electrode for lithium ion secondary battery comprising negative electrode active material containing two carbons and method for manufacturing lithium ion secondary battery comprising same NEC CORPORATION (JP) 2019-02-19 US disclosed
US-9923239-B2 Lithium ion battery NEC ENERGY DEVICES, LTD. (JP) 2018-03-20 US disclosed
US-20100092869-A1 LITHIUM ION BATTERY NEC TOKIN CORPORATION (JP) 2010-04-15 US disclosed
US-20100062332-A1 LITHIUM ION SECONDARY BATTERY NEC TOKIN CORPORATION (JP) 2010-03-11 US disclosed
US-7662519-B2 contains cyclic disulfonic acid esters; improved energy density and electromotive force, cycle life, storage property and safety NEC CORPORATION (JP) 2010-02-16 US disclosed
US-7662519-B2 contains cyclic disulfonic acid esters; improved energy density and electromotive force, cycle life, storage property and safety NEC CORPORATION (JP) 2010-02-16 US disclosed
US-20070154815-A1 Secondary battery NEC CORPORATION (JP) 2007-07-05 US disclosed
US-20070154815-A1 Secondary battery NEC CORPORATION (JP) 2007-07-05 US disclosed
US-20070054179-A1 Non-aqueous electrolyte secondary battery NEC CORPORATION (JP) 2007-03-08 US disclosed
US-20070054179-A1 Non-aqueous electrolyte secondary battery NEC CORPORATION (JP) 2007-03-08 US disclosed
US-7163768-B2 Solvent stability; battery NEC CORPORATION (JP) 2007-01-16 US disclosed
US-7163768-B2 Solvent stability; battery NEC CORPORATION (JP) 2007-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144668-A1 LITHIUM ION SECONDARY BATTERY, MANUFACTURING METHOD OF LITHIUM ION SECONDARY BATTERY, AND ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY SOD3, KCNN3, SCLY TSHR 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.